Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

22.52
-0.0200-0.09%
Post-market: 23.000.4800+2.13%16:10 EDT
Volume:1.68M
Turnover:37.78M
Market Cap:3.60B
PE:-69.22
High:22.99
Open:22.72
Low:21.93
Close:22.54
52wk High:23.15
52wk Low:9.96
Shares:159.76M
Float Shares:126.00M
Volume Ratio:0.60
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3254
EPS(LYR):-0.3922
ROE:-23.95%
ROA:-5.74%
PB:16.63
PE(LYR):-57.43

Loading ...

Adaptive Biotechnologies CSO Harlan S. Robins sells 106,160 shares for $1.85 million

Reuters
·
Jun 18

BUZZ-U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron

Reuters
·
Jun 17

Adaptive Biotechnologies Price Target Maintained With a $22.00/Share by BTIG

Dow Jones
·
Jun 17

Adaptive Biotechnologies prices $300M convertible senior note offering

TIPRANKS
·
Jun 17

BUZZ-U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile

Reuters
·
Jun 17

BUZZ-Adaptive Biotechnologies up after boosted $300 mln convertible bond sale

Reuters
·
Jun 17

Adaptive Biotechnologies prices upsized USD 300 million 0% convertible senior notes offering due 2031

Reuters
·
Jun 17

Adaptive Biotechnologies - Prices $300 Mln 0% Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 17

Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering

GlobeNewswire
·
Jun 17

MRD Spinoff And $250 Million Convertible Notes Could Be A Game Changer For Adaptive Biotechnologies (ADPT)

Simply Wall St.
·
Jun 17

Analysts Are Bullish on Top Healthcare Stocks: Pasithea Therapeutics Corp (KTTA), Adaptive Biotechnologies (ADPT)

TIPRANKS
·
Jun 16

Adaptive Biotechnologies offers to sell $250M in 2031 convertible senior notes

TIPRANKS
·
Jun 16

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 common shares for $95,000

Reuters
·
Jun 16

Stocks to Watch: Dave & Buster's, Adaptive Biotechnologies, Domo, Apollo Commercial Real Estate Finance

Dow Jones
·
Jun 16

BRIEF-Adaptive Biotechnologies Announces Proposed Convertible Senior Notes Offering

Reuters
·
Jun 16

Adaptive Biotechnologies Evaluates Strategic Alternatives for Immune Medicine Business

Dow Jones
·
Jun 16

Adaptive Biotechnologies Weighs Separation of Immune Medicine Unit; Shares Fall After Hours

MT Newswires Live
·
Jun 16

BUZZ-Adaptive Biotechnologies falls after announcing convertible, separation of businesses

Reuters
·
Jun 16

Adaptive to plans to separate minimal residual disease, immune medicine segments

TIPRANKS
·
Jun 16

Adaptive Biotechnologies plans separation of MRD, Immune Medicine units

Reuters
·
Jun 16